M&T Bank Corp boosted its stake in shares of Envista Holdings Co. (NYSE:NVST – Free Report) by 42.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,945 shares of the company’s stock after buying an additional 4,787 shares during the period. M&T Bank Corp’s holdings in Envista were worth $315,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also recently made changes to their positions in the company. Ariel Investments LLC boosted its position in Envista by 11.0% during the second quarter. Ariel Investments LLC now owns 9,871,152 shares of the company’s stock valued at $164,157,000 after purchasing an additional 978,952 shares in the last quarter. Nuance Investments LLC boosted its holdings in shares of Envista by 4.4% in the 3rd quarter. Nuance Investments LLC now owns 7,346,534 shares of the company’s stock valued at $145,168,000 after buying an additional 308,221 shares in the last quarter. American Century Companies Inc. raised its stake in shares of Envista by 15.4% during the 2nd quarter. American Century Companies Inc. now owns 6,726,651 shares of the company’s stock worth $111,864,000 after acquiring an additional 897,141 shares in the last quarter. Clarkston Capital Partners LLC lifted its position in Envista by 0.4% during the third quarter. Clarkston Capital Partners LLC now owns 4,347,300 shares of the company’s stock valued at $85,903,000 after acquiring an additional 17,085 shares during the last quarter. Finally, Jupiter Asset Management Ltd. acquired a new stake in Envista in the second quarter valued at approximately $69,534,000.
Envista Trading Down 5.4 %
Shares of Envista stock opened at $18.20 on Thursday. Envista Holdings Co. has a 1 year low of $15.15 and a 1 year high of $25.64. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77. The stock has a market cap of $3.13 billion, a PE ratio of -2.34, a price-to-earnings-growth ratio of 2.71 and a beta of 1.31. The firm has a fifty day moving average price of $20.12 and a 200 day moving average price of $18.44.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on NVST shares. Mizuho started coverage on Envista in a research report on Wednesday, December 4th. They issued an “underperform” rating and a $20.00 price objective for the company. Leerink Partnrs upgraded Envista from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 31st. Stifel Nicolaus upped their price objective on shares of Envista from $18.00 to $21.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Leerink Partners upgraded shares of Envista from an “underperform” rating to a “market perform” rating and lifted their target price for the stock from $16.00 to $23.00 in a research note on Thursday, October 31st. Finally, Needham & Company LLC restated a “hold” rating on shares of Envista in a research note on Thursday, October 31st. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Envista currently has a consensus rating of “Hold” and a consensus target price of $20.65.
Get Our Latest Stock Report on NVST
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Recommended Stories
- Five stocks we like better than Envista
- The Most Important Warren Buffett Stock for Investors: His Own
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Insider Trades May Not Tell You What You Think
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- What to Know About Investing in Penny Stocks
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.